Overview
Shubham Pant is a Hematologist Oncology specialist and a Hematologist in Houston, Texas. Dr. Pant is rated as an Experienced provider by MediFind in the treatment of Hemangiopericytoma. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Cholangiocarcinoma (Bile Duct Cancer), Hepato-Pancreato-Biliary Surgery, and Pancreatectomy.
His clinical research consists of co-authoring 168 peer reviewed articles and participating in 21 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2130 W Holcombe Blvd, Univ Of Tx M D Ande Life, Houston, TX 77030
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
20 Clinical Trials
George Van Buren, II, M.D. is an associate professor of surgery in the Division of Surgical Oncology of the Michael E. DeBakey Department of Surgery at Baylor College of Medicine. Dr. Van Buren is a board-certified surgeon specializing surgical oncology and pancreatic disorders.A native Houstonian, Dr. Van Buren earned his undergraduate degree at the University of Texas at Austin and his medical degree at the University of Texas Medical School at Houston. He completed his general surgery residency at the University of Texas Medical School at Houston. During that time period, he spent two years at MD Anderson Cancer Center as an NIH T32 research fellow studying pancreatic cancer and neuroendocrine tumors. He completed his surgical oncology fellowship at the University of Pittsburgh Medical Center in the Translational Pancreas Research Track.During Dr. Van Buren’s research and clinical fellowships, he was able to expand upon his interest in gastrointestinal surgical oncology and pancreatic disorders. Specifically, his training had a heavy emphasis on pancreatic and gastric malignancies with exposure to wide breadth of cases, including specialized procedures such as robotic pancreatic surgery.Dr. Van Buren is active in both patient care and research. He has spent over 15 years in training and in practice focusing on care for patients with pancreatic and gastrointestinal malignancies. He is involved in both basic science and clinical research and believes heavily in the surgeon’s role as a leader of the translational research team. His goals are to provide high quality clinical care while offering his patients access to innovative clinical and therapeutic trials. He is a member of the Elkins Pancreas Center and Dan L. Duncan NCI Cancer Center at Baylor College of Medicine. Dr. Van Buren is rated as an Advanced provider by MediFind in the treatment of Hemangiopericytoma. His top areas of expertise are Pancreatic Cancer, Gallbladder Adenocarcinoma, Gallbladder Cancer, Splenectomy, and Pancreatectomy.
MD Anderson
Anthony Conley is an Oncologist in Houston, Texas. Dr. Conley is rated as an Elite provider by MediFind in the treatment of Hemangiopericytoma. His top areas of expertise are Adult Soft Tissue Sarcoma, Chondrosarcoma, Alveolar Soft Part Sarcoma, Liposarcoma, and Salpingo-Oophorectomy.
MD Anderson
Maria Zarzour is an Oncologist in Houston, Texas. Dr. Zarzour is rated as an Elite provider by MediFind in the treatment of Hemangiopericytoma. Her top areas of expertise are Adult Soft Tissue Sarcoma, Alveolar Soft Part Sarcoma, Liposarcoma, and Undifferentiated Pleomorphic Sarcoma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Cholangiocarcinoma (Bile Duct Cancer)
- Pancreatic CancerDr. Pant isElite. Learn about Pancreatic Cancer.
- Pancreatic Ductal Adenocarcinoma
- Distinguished
- Adult Soft Tissue SarcomaDr. Pant isDistinguished. Learn about Adult Soft Tissue Sarcoma.
- Ampullary CancerDr. Pant isDistinguished. Learn about Ampullary Cancer.
- Endometrial CancerDr. Pant isDistinguished. Learn about Endometrial Cancer.
- Familial Pancreatic CancerDr. Pant isDistinguished. Learn about Familial Pancreatic Cancer.
- Gallbladder AdenocarcinomaDr. Pant isDistinguished. Learn about Gallbladder Adenocarcinoma.
- Gallbladder CancerDr. Pant isDistinguished. Learn about Gallbladder Cancer.
- Advanced
- Breast CancerDr. Pant isAdvanced. Learn about Breast Cancer.
- Clear Cell SarcomaDr. Pant isAdvanced. Learn about Clear Cell Sarcoma.
- Colorectal CancerDr. Pant isAdvanced. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Pant isAdvanced. Learn about Familial Colorectal Cancer.
- Familial Prostate CancerDr. Pant isAdvanced. Learn about Familial Prostate Cancer.
- Gallbladder DiseaseDr. Pant isAdvanced. Learn about Gallbladder Disease.
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- Adenoid Cystic CarcinomaDr. Pant isExperienced. Learn about Adenoid Cystic Carcinoma.
- Adrenal CancerDr. Pant isExperienced. Learn about Adrenal Cancer.
- Adrenocortical CarcinomaDr. Pant isExperienced. Learn about Adrenocortical Carcinoma.
- AgranulocytosisDr. Pant isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer
